Edges in Network
Network | GSE12093_egf1520 - GSE12093 - SiGN-BN HC+Bootstrap |
Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
Node | SMO |
Upstream (Parents) |
---|
(<<) ADCY6 → SMO |
(<<) ARHGEF2 → SMO |
(<<) ASB1 → SMO |
(<<) E2F6 → SMO |
(<<) GRK6 → SMO |
(<<) HMGCR → SMO |
(<<) ILKAP → SMO |
(<<) KLF11 → SMO |
(<<) MAP3K11 → SMO |
(<<) PLCD1 → SMO |
(<<) RAB15 → SMO |
(<<) SMAD2 → SMO |
(<<) TOP2B → SMO |
(<<) YWHAQ → SMO |
Downstream (Children) |
---|
SMO → ATF2 (>>) |
SMO → CABC1 (>>) |
SMO → CAMKK2 (>>) |
SMO → CEACAM1 (>>) |
SMO → CTPS (>>) |
SMO → E2F5 (>>) |
SMO → EREG (>>) |
SMO → FOXC2 (>>) |
SMO → FZD9 (>>) |
SMO → GAD1 (>>) |
SMO → ITPR2 (>>) |
SMO → MAPKAP1 (>>) |
SMO → NCOR2 (>>) |
SMO → PIK3R2 (>>) |
SMO → PLA2R1 (>>) |
SMO → POLR1B (>>) |
SMO → PTPN11 (>>) |
SMO → RAB22A (>>) |
SMO → STAM2 (>>) |